Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3001746 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Derek A G Barisas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America. Hauptthemen laut MEDLINE: Hematopoiesis, Extramedullary, Hematologic Diseases, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Extramedullary hematopoiesis (EMH) expands hematopoietic capacity outside of the bone marrow in response to inflammatory conditions, including infections and cancer. Because of its inducible nature, EMH offers a unique opportunity to study the interaction between hematopoietic stem and progenitor cells (HSPCs) and their niche. In cancer patients, the spleen frequently serves as an EMH organ and provides myeloid cells that may worsen pathology. Here, we examined the relationship between HSPCs and their splenic niche in EMH in a mouse breast cancer model. We identify tumor produced IL-1α and leukemia inhibitory factor (LIF) acting on splenic HSPCs and splenic niche cells, respectively. IL-1α induced TNFα expression in splenic HSPCs, which then activated splenic niche activity, while LIF induced proliferation of splenic niche cells. IL-1α and LIF display cooperative effects in activating EMH and are both up-regulated in some human cancers. Together, these data expand avenues for developing niche-directed therapies and further exploring EMH accompanying inflammatory pathologies like cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
- Immunology Program, Washington University School of Medicine, St. Louis, Missouri, United States of America.
- Medical Scientist Training Program, Washington University School of Medicine, St. Louis, Missouri, United States of America.
- Developmental and Regenerative Biology, A*STAR Skin Research Laboratories, Singapore, Singapore.
ORCID-Profile: Derek A G Barisas
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Foundation for Barnes-Jewish Hospital
Zitieren
APA
Barisas, D. A. G., Kabir, A. U., Wu, J., Krchma, K., Kim, M., Subramanian, M., Zinselmeyer, B. H., Stewart, C. L., & Choi, K. (2023). Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis. PLOS Biology. https://doi.org/10.1371/journal.pbio.3001746
Vancouver
Barisas DAG, Kabir AU, Wu J, Krchma K, Kim M, Subramanian M, et al. Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis. PLOS Biology. 2023. doi:10.1371/journal.pbio.3001746
BibTeX
@article{Barisas2023,
author = {Barisas, Derek A G and Kabir, Ashraf Ul and Wu, Jun and Krchma, Karen and Kim, Minseo and Subramanian, Madhav and Zinselmeyer, Bernd H and Stewart, Colin L and Choi, Kyunghee},
title = {Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3001746}
}
EUVIMED